SPY772.04+0.09%QQQ745.40+0.12%BTC/USD84,129.63+0.04%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%
Benzinga

Aquestive Therapeutics Inc (AQST) Stock Price, Quote, News & History

AQSTNASDAQ
Trade with Public
Trade with Public
$4.68
-0.14-2.9%
At close: Sep 25, 5:00 PM EST
$4.87
0.194.15%
After Hours: 6:41 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Aquestive Therapeutics (AQST) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$4.82
Close
$4.68
Volume / Avg.
1.91M / 2.78M
Day Range
$4.66 - $4.86
52 Wk Range
2.93 - 7.55
Market Cap
$611.76M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
22.65%
Days to Cover
11.81

Recent Aquestive Therapeutics, Inc. News

Aquestive Therapeutics Resubmits FDA Application for Pocket-Sized Allergy Treatment

Aquestive Therapeutics has resubmitted its New Drug Application to the FDA for Anaphylm, a sublingual film for severe allergic reactions.
Vandana Singh

Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study

Aquestive Therapeutics reports positive study results for Anaphylm sublingual film, paving the way for a Q3 FDA resubmission.
Vandana Singh

Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Higher On Monday

BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained 16.4%, AQST gained 15.4%, STDN rose 13.7%.
Avi Kapoor

Staar Surgical Posts Upbeat Q1 Results, Joins Cisco, Yeti Holdings And Other Big Stocks Moving Higher On Thursday

U.S. stocks rose, with Dow Jones up 300 points. STAA shares surged after better-than-expected results. Other big gainers include POET, STUB, MSC, ARX, CSCO, PCT, WOLF, CPA, ONDS, KLAR, and RDW.
Avi Kapoor

What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment?

Aquestive received an FDA rejection for its allergy film due to safety and use issues. The company plans new studies and targets resubmission in 2026.
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-45.37M
Investing Cash Flow (TTM)
-584.00K
Financing Cash Flow (TTM)
83.90M
Free Cash Flow (TTM)
-45.95M
Capital Expenditure (TTM)
-584.00K
Net Change in Cash (TTM)
37.95M

Analyst Trends and Forecast

1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.5
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$546.68M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
10.70
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-13.69%
Earnings Yield % (FWD)
-10.58%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.45

Company Debt

Total Debt
$50.69M
LT Debt
$50.65M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$48.92M
Total Cash
$98.49M
Debt to Equity
-
Issuance of Debt (TTM)
$5.42M
Repayment of Debt (TTM)
-$48.92M

Key Statistics

Open
$4.82
Close
$4.68
Volume / Avg.
1.91M / 2.78M
Day Range
$4.66 - $4.86
52 Wk Range
2.93 - 7.55
Market Cap
$611.76M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
22.65%
Days to Cover
11.81

About

Sector
Health Care
Industry
Pharmaceuticals
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Aquestive Therapeutics (AQST) stock?

A

You can purchase shares of Aquestive Therapeutics (NASDAQ:AQST) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aquestive Therapeutics (AQST) competitors?

Q

What is the forecast, or price target, for Aquestive Therapeutics (AQST) stock?

A

Aquestive Therapeutics has a consensus price target of $9.90.

Q

What is the current price for Aquestive Therapeutics (AQST)?

A

The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $4.8741 last updated September 25, 2026 at 6:41 PM EDT.

Q

Does Aquestive Therapeutics (AQST) pay a dividend?

A

There are no upcoming dividends for Aquestive Therapeutics.

Q

When is Aquestive Therapeutics (NASDAQ:AQST) reporting earnings?

A

Aquestive Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aquestive Therapeutics (AQST) going to split?

A

There is no upcoming split for Aquestive Therapeutics.

Q

What sector and industry does Aquestive Therapeutics (AQST) operate in?

A

Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved